Effects of Vented Base Feeding Bottle in Preterm Infants With GERD Symptoms.
FeedGERD
Vented Base Feeding Bottle in Preterm Infants With GERD Symptoms: Effects on Respiration-swallow Patterns and Reflux.
1 other identifier
interventional
30
1 country
1
Brief Summary
Aim of the study is to evaluate the effects of vented base bottles on respiration-swallow patterns and on gastroesophageal refluxes in preterm infants with clinical suspect of gastroesophageal reflux disease (GERD). In this crossover-randomized study, we compared the effects of standard feeding bottles (A) versus vented base feeding bottles (B) on a group of patients with at least 2 clinical GERD symptoms. 24 hours of synchronized cardiorespiratory (CR) and Esophageal Multichannel intraluminal impedance (MII/pH) monitoring were evaluated for each patient. During this period, patients were fed alternatively with feeding bottle A and B.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 12, 2017
CompletedFirst Posted
Study publicly available on registry
January 25, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedMarch 31, 2020
March 1, 2020
1.9 years
January 12, 2017
March 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Frequency of cardiorespiratory events (feeding+postprandial time)
Cardiorespiratory events / hour * apnea (no breathing movement for at least 20 s, or less if associated with desaturation/bradycardia) * desaturation (SpO2 \<80%) * bradycardia (heart rate \< 80 bpm for at least 1 s)
calculated throughout 24 hour
Secondary Outcomes (2)
Swallow event characteristics (feeding time)
calculated throughout 30 minute interval after the beginning of the milk meal
Frequency of reflux events (postprandial time)
calculated throughout 150 minute interval after the end of the milk meal
Study Arms (2)
Start feeding with Device A, "standard"
EXPERIMENTALAlternatively feeding with standard feeding bottle (Device A) and vented base feeding bottle (Device B)
Start feeding with Device B, "vented"
EXPERIMENTALAlternatively feeding with vented base feeding bottle (Device B) and standard feeding bottle (Device A)
Interventions
Eligibility Criteria
You may qualify if:
- weight ≥ 1500 g at the time of examination
- at least 2 GERD symptoms
- exclusive enteral feeding
- parents' informed consent
You may not qualify if:
- congenital abnormalities
- perinatal asphyxia
- respiratory, genetic, metabolic, infectious and/or neurologic disease
- pharmacological therapies, in the last 7 days, able to affect esophageal motility
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ospedale S.Anna di Torino
Torino, (TO), 10126, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Francesco Cresi, MD PhD
University of Turin, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD PhD
Study Record Dates
First Submitted
January 12, 2017
First Posted
January 25, 2017
Study Start
January 1, 2017
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
March 31, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share